Bio-Rad Laboratories

Bio-Rad Laboratories

Yahoo Finance • 14 days ago

Bio-Rad (BIO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 5 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Ruben ArguetaChief Executive Officer - Norman SchwartzPresident and Chief Operating Officer - Jonathan DiVincenzoExec... Full story

Yahoo Finance • 14 days ago

Non-Viral Transfection Reagents Market Report (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User & Region, Featuring Bio-Rad, MaxCyte, MilliporeSigma, Thermo Fisher Scientific

Company Logo Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents Market (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User and Geographical Regions-Trends and Forecast Till 2035"... Full story

Yahoo Finance • 21 days ago

Bio-Rad forecasts 2026 currency-neutral revenue growth of (-3%) to +0.5% while targeting $30M-$35M net cost savings by end of 2027

Earnings Call Insights: Bio-Rad Laboratories (BIO) Q2 2026 MANAGEMENT VIEW * "Total company revenue in the second quarter was approximately $651 million, essentially flat as reported and down 1.9% on a currency-neutral basis compared w... Full story

Yahoo Finance • 21 days ago

SR Inc Net Zero Consortium for Buyers: Seven-Buyer Aggregation for 180 MW of Millers Branch Solar Now Online

BOSTON, Aug. 4, 2026 /PRNewswire/ -- The 180 MW Phase II portion of the Millers Branch Solar Facility in Haskell County, Texas has achieved commercial operation. The capacity was contracted through Sustainability Roundtable, Inc's Net Zero... Full story

Yahoo Finance • last month

Longleaf Partners Fund exits BIO

* Longleaf Partners Fund underperformed with a return of 3.87% in Q2, as compared to the S&P 500's 15.20% gain and the Russell 1000 Value Index's 13.87% advance. * The fund initiated one new position in a healthcare company during Q2 2... Full story

Yahoo Finance • 2 months ago

Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Hematologic Malignancies Testing Market size & share revenue was valued at approximat... Full story

Yahoo Finance • 2 months ago

Global Fluorescent In Situ Hybridization Probe Market Size/Share Worth USD 2.27 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Fluorescent In Situ Hybridization Probe Market size & share revenue was valued at app... Full story

Yahoo Finance • 3 months ago

Kinaxis Unveils 2026 Customer Award Winners at Kinexions in Las Vegas

Global supply chain leaders recognized for delivering bold innovation, agility, and measurable impact LAS VEGAS, June 04, 2026--(BUSINESS WIRE)--Kinaxis® (TSX: KXS), a global leader in end-to-end supply chain planning and orchestration, t... Full story

Yahoo Finance • 3 months ago

Stocks Pressured by a Rebound in Crude Prices and Bond Yields

The S&P 500 Index ($SPX) (SPY) today is down -0.20%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.04%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.57%.  June E-mini S&P futures (ESM26) are down -0.28%, and June E-mini Na... Full story

Yahoo Finance • 3 months ago

Stocks Mixed as Crude Oil Prices and Bond Yields Fall

The S&P 500 Index ($SPX) (SPY) today is up +0.07%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.29%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.25%.  June E-mini S&P futures (ESM26) are up +0.10%, and June E-mini Nasdaq f... Full story

Yahoo Finance • 3 months ago

Stocks making the biggest moves midday: Regeneron, Dominion, Mobileye, Viking and more

Check out the companies making the biggest moves in midday trading: Dominion Energy — Shares popped more than 9% after NextEra Energy announced a deal to acquire the company in an all-stock transaction. NextEra said the combination of the... Full story

Yahoo Finance • 3 months ago

Sector Update: Healthcare Stocks Decline Pre-Bell Monday

Healthcare stocks were declining pre-bell Monday, with the State Street Health Care Select Sector SP PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

Stocks making the biggest moves premarket: Regeneron, Dominion Energy, Macy's & more

Check out the companies making the biggest moves premarket: Regeneron Pharmaceuticals — The drugmaker fell more than 11% after its treatment for a skin cancer missed goals in a late-stage trial. Macy's — The department store shares jumped... Full story

Yahoo Finance • 3 months ago

AM Markets Need to Know: Elliott and Bio-Rad, Ebola outbreak, and more

[Global Commerce and Business logistics] Stock index futures fell Monday as traders awaited Nvidia (NVDA [https://seekingalpha.com/symbol/NVDA]) and retail earnings reports slated to come later in the week. Now, here are 5 news stories t... Full story

Yahoo Finance • 4 months ago

Ariel Investments Re-added Bio-Rad Laboratories (BIO) as Strong Margins and Market Leadership Stand Out

Ariel Investments, an investment management company, released its “Ariel Focus Fund" Q1 2026 Investor Letter. A copy of the letter can be downloaded here. The fund reported strong first-quarter performance for its Ariel Focus Fund, which g... Full story

Yahoo Finance • 4 months ago

How The Biocon (NSEI:BIOCON) Story Is Shifting As Analysts Recut Growth And Risk Assumptions

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Biocon’s fair value estimate has been trimmed slightly from ₹420.74 to about ₹416.53, signalling a modest reset in how analysts ar... Full story

Yahoo Finance • 4 months ago

Bio-Rad (BIO) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, July 31, 2025 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Norman D. Schwartz President and Chief Operating Officer — Jonathan P. DiVincenzo Executive Vice President and Chief F... Full story

Yahoo Finance • 4 months ago

Here are the major earnings after the close Thursday

Major earnings expected after the bell on Thursday include: * Apple (AAPL [https://seekingalpha.com/symbol/AAPL]) * Amgen (AMGN [https://seekingalpha.com/symbol/AMGN]) * Roku (ROKU [https://seekingalpha.com/symbol/ROKU]) * Twilio... Full story

Yahoo Finance • 5 months ago

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Ameriprise Financial, Arista Networks, Arm Holdings, Lennar, Morgan Stanley, Rocket Lab, Tractor Supply, Wingstop, Wix.com and More

Quick Read The stock market started the first full trading week of the second quarter on a positive note. Investors and analysts will be anxiously awaiting first-quarter earnings results that will start in earnest next week with the large... Full story

Yahoo Finance • 5 months ago

Artisan Mid Cap Value Fund Sold Bio-Rad Laboratories (BIO) in Q4

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Value Fund”.  A copy of the letter can be downloaded here. The Fund seeks to invest in undervalued companies with sol... Full story